Wang Fang,Ma Yuanye,Yang Dongbing,Dong Cheng,Liu Wenyan,Zhang Ziming,Efficacy of sertraline combined with low-dose olanzapine in patients with depression and anxiety comorbidity[J].SICHUAN MENTAL HEALTH,2021,34(2):135-138
Efficacy of sertraline combined with low-dose olanzapine in patients with depression and anxiety comorbidity
DOI:10.11886/scjsws20201106002
English keywords:Sertraline  Olanzapine  Depression and anxiety comorbidity  Sleep
Fund projects:
Author NameAffiliationPostcode
Wang Fang The Third People's Hospital of Tianshui Tianshui 741000 China 741000
Ma Yuanye The Third People's Hospital of Tianshui Tianshui 741000 China 741000
Yang Dongbing The Third People's Hospital of Tianshui Tianshui 741000 China 741000
Dong Cheng The Sanatorium for Mental Illness of Veterans in Tianshui Tianshui 741000 China 741000
Liu Wenyan The Third People's Hospital of Tianshui Tianshui 741000 China 741000
Zhang Ziming The Third People's Hospital of Tianshui Tianshui 741000 China 741000
Hits:
Download times:
English abstract:
      Objective To observe the efficacy and safety of sertraline combined with low-dose olanzapine in the treatment of depression and anxiety comorbidity and its effect on sleep quality, so as to provide references for the related clinical treatment.Methods A total of 121 patients who met the diagnostic criteria of International Classification of Diseases, tenth edition (ICD-10) for depressive episode and generalized anxiety disorder in The Third People's Hospital of Tianshui and the Sanatorium for Mental Illness of Veterans in Tianshui from October 2019 to August 2020 were enrolled, and they were divided into two groups according to the random number table method. Study group (n=61) received sertraline combined with low-dose olanzapine, while control group (n=60) received sertraline only. Then the disease severity degree, sleep quality and adverse reactions were assessed using Hamilton Depression Scale - 17 item (HAMD-17), Hamilton Anxiety Scale (HAMA), Pittsburgh Sleep Quality Index (PSQI) and Treatment Emergent Symptom Scale (TESS) at the baseline, 1st, 2nd, 4th, 6th and 8th weekend, respectively.Results Post-treatment HAMD-17, HAMA and PSQI scores in both groups were lower than those before treatment (P<0.05). At each time point after treatment, HAMD-17, HAMA and PSQI scores of study group were lower than those of control group, with statistical significance (P<0.05).Conclusion Sertraline alone and its combination with low-dose olanzapine are both effective in the treatment of depression and anxiety comorbidity, while the combination therapy achieves better efficacy and higher safety in alleviating anxiety and insomnia symptoms.
View Full Text   View/Add Comment  Download reader
Close